BMJ 1998;316:1570-1571 ( 23 May )

Papers

Initiatives to improve childhood immunisation uptake: a randomised controlled trial

Maria Z Morgan, research officerMeirion R Evans, consultant in communicable disease control

Public Health Directorate, Bro Taf Health Authority, Temple of Peace and Health, Cardiff CF1 3NW

Correspondence to: Dr Evans mre{at}abton4.demon.co.uk

Levels of childhood immunisation are high in the United Kingdom but are proving difficult to maintain. Several initiatives to improve uptake have been described, including sending written information to parents,1 specialist immunisation clinics,2 and prompts to health visitors and general practitioners.3 However, none of these interventions has been the subject of a randomised controlled trial. We tested the effectiveness of two such interventions.

    Subjects, methods, and results
Top
Subjects and methods
Comment
References

The child health system, which maintains computerised data on immunisation status of all children, was used as the sampling frame. The study population comprised children resident in the former county of South Glamorgan who were (a) born between 1 April and 30 September 1995 and scheduled to complete the primary course of diphtheria, pertussis, tetanus, polio, and Haemophilus influenzae type b immunisation or (b) born between 1 April and 30 September 1994 and scheduled to receive measles, mumps, and rubella immunisation. Children were included in the trial if they had not completed their primary course by 9 months of age or their measles, mumps, and rubella immunisation by 21 months of age.

Each week between 1 January and 30 June 1996 we received a computer generated list of children eligible for inclusion in the study and randomised each child using computer generated random numbers to one of two interventions or a control group. Intervention A comprised a non-directive telephone call to the child's health visitor to confirm the child's personal details and immunisation status. The health visitor was not informed of the trial and, although follow up of the child was anticipated, it was not specifically requested. Intervention B comprised a single mailed reminder to the child's parents together with a questionnaire about details of immunisation status and reasons for non-immunisation, and a reply paid envelope. Parents were not informed of the trial.

Study end points were completion of (a) primary immunisation by the first birthday or (b) measles, mumps, and rubella immunisation by the second birthday. We performed statistical analysis on an intention to treat basis, using the chi 2 test with Yates's correction for baseline comparisons, and calculated 95% confidence intervals for the difference in proportions.

                              
View this table:
[in this window]
[in a new window]
 

Baseline characteristics and immunisation uptake in intervention and control groups. Values are numbers (percentages) of subjects unless stated otherwise

In total, 153 children (76 primary course and 77 measles, mumps, and rubella immunisation) were randomised to intervention A, 159 children (82 primary course and 77 measles, mumps, and rubella immunisation) to intervention B, and 139 children (74 primary course and 65 measles, mumps, and rubella immunisation) to the control group. The study had a power of 80% to show a 15% difference between each intervention and the control group at 5% two sided significance. Distribution of baseline characteristics in the three groups was similar. There was no significant difference between either intervention group and the control group in the proportion completing the primary course or measles, mumps, and rubella immunisation (see table). Nor was there a significant difference in study end point, when both interventions combined were compared with the control group. Subgroup analysis by maternal age and parity showed a substantial but non-significant effect of intervention in promoting completion of primary immunisation in firstborn children (56%, 10/18) compared with firstborn controls (25%, 3/12), and in children of young mothers aged =<30 years (31%, 27/86) compared with controls (13%, 5/38). There was no effect on uptake of measles, mumps, and rubella immunisation.

    Comment
Top
Subjects and methods
Comment
References

Randomised controlled trials provide the best evidence for effectiveness of interventions. However, we found only one other trial of an intervention to promote childhood immunisation. This was carried out in preschool children in the United States and found that a computer generated telephone reminder resulted in a significant but modest improvement of 12% in immunisation uptake in the intervention group, after excluding the 20% of households with no telephone.4

Neither intervention we studied improved immunisation uptake. The results suggest that district-wide initiatives directed at individual families are unlikely to be worth while, although there may be some benefit from targeting young or primiparous mothers. There is evidence that initiatives by primary healthcare teams such as opportunistic immunisation of children attending the surgery and domiciliary immunisation by nurses can improve uptake,5 although these approaches would benefit from more formal evaluation. More use should be made of randomised controlled trials to evaluate interventions to promote uptake of preventive services in primary care.

    Acknowledgments

We thank the child health support team at the Welsh Health Common Services Authority for providing immunisation data; Mrs Margaret Morgan, Cardiff Community Healthcare NHS Trust, for her invaluable assistance; and Dr Frank Dunstan, Department of Medical Statistics and Computing, University of Wales College of Medicine, for statistical advice.

Contributors: MZM helped design the protocol, collected and analysed the data, and helped write the article. MRE conceived, designed, and supervised the study; wrote the article; and is the guarantor.

Funding: None.

Conflict of interest: None.

    References
Top
Subjects and methods
Comment
References

  1. Brambleby P, Hanrahan J. Measles immunisation non-acceptance: validation of computer-held records and raising the vaccine uptake at early school age: the Maidstone experience. Public Health 1989; 103: 289-294[Medline].
  2. Newport MJ, Conway SP. Experience of a specialist service for advice on childhood immunisation. J Infect 1993; 26: 295-300[Medline].
  3. Crittenden P, Rao M. The immunisation coordinator: improving uptake of childhood immunisation. Commun Dis Rep CDR Rev 1994; 4: R79-R81[Medline].
  4. Stehr-Green PA, Dini EF, Lindergren ML, Patriarca PA. Evaluation of telephone computer-generated reminders to improve immunisation coverage at inner city clinics. Public Health Reports 1993; 108: 426-430[Medline].
  5. Peckham C, Bedford H, Seturia Y, Ades A. The Peckham report---national immunisation study: factors influencing immunisation uptake in childhood. London: Action for the Crippled Child , 1989.

(Accepted 6 May 1998)


© BMJ 1998

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Conjugate Hib vaccines given in infancy without booster doses may produce long term protection
BMJ 1998 316: 0. [Full Text]

This article has been cited by other articles:

  • Heath, P T, McVernon, J (2002). The UK Hib vaccine experience. Arch. Dis. Child. 86: 396-399 [Abstract] [Full text]  
  • Garpenholt, O., Fredlund, H., Timpka, T. (2001). Immunization against Haemophilus infl uenzae type b in Sweden- A study of the introduction process. Scand J Public Health 29: 271-278 [Abstract]  
  • Borrow, R., Andrews, N., Goldblatt, D., Miller, E. (2001). Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of Protection. Infect. Immun. 69: 1568-1573 [Abstract] [Full text]  
  • Heath, P. T., Booy, R., Azzopardi, H. J., Slack, M. P. E., Bowen-Morris, J., Griffiths, H., Ramsay, M. E., Deeks, J. J., Moxon, E. R. (2000). Antibody Concentration and Clinical Protection After Hib Conjugate Vaccination in the United Kingdom. JAMA 284: 2334-2340 [Abstract] [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ